Related references
Note: Only part of the references are listed.RNA protein kinase SNP at-226 C<T is a biomarker for the clearance of HCV among Egyptian patients
Ahmed Wahid et al.
IMMUNOLOGICAL INVESTIGATIONS (2019)
Impact of IL-27p28 (rs153109) and TNF-α (rs1800629) Genetic Polymorphisms on the Progression of HCV Infection in Egyptian Patients
Ebram Tharwat et al.
IMMUNOLOGICAL INVESTIGATIONS (2019)
Preface
Emilio Jirillo
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2019)
EASL Recommendations on Treatment of Hepatitis C 2018
JOURNAL OF HEPATOLOGY (2018)
High spontaneous clearance of symptomatic iatrogenic acute hepatitis C genotype 4 infection
Mohamed Hashem et al.
JOURNAL OF MEDICAL VIROLOGY (2018)
IL28B rs12980275 and HLA rs4273729 genotypes as a powerful predictor factor for rapid, early, and sustained virologic response in patients with chronic hepatitis C
Parvaneh Sedighimehr et al.
ARCHIVES OF VIROLOGY (2017)
Simeprevir plus sofosbuvir for eight or 12 weeks in treatment-naive and treatment-experienced hepatitis C virus genotype 4 patients with or without cirrhosis
M. El Raziky et al.
JOURNAL OF VIRAL HEPATITIS (2017)
EGFR rs11506105 and IFNL3 SNPs but not rs8099917 are strongly associated with treatment responses in Iranian patients with chronic hepatitis C
M. Asnavandi et al.
GENES AND IMMUNITY (2017)
Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection
Mohammad Irshad et al.
WORLD JOURNAL OF HEPATOLOGY (2017)
Polymorphisms at IL28B Gene as Predictors of Viral Relapse in Genotype 4 Egyptian Hepatitis C Patients
Mona Abdelmonem Esmail et al.
JOURNAL OF MEDICAL VIROLOGY (2016)
Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post-liver transplantation recurrence
Fred Poordad et al.
HEPATOLOGY (2016)
Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies
C. Estes et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Influence of IFNL3.rs12979860 and IFNL4.ss469415590 polymorphism on clearance of hepatitis C virus infection among Egyptians
Susanne Knapp et al.
HEPATOLOGY INTERNATIONAL (2015)
Interferon-free regimens for the treatment of hepatitis C virus in liver transplant candidates or recipients
Evangelos Cholongitas et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Characterization of the Interleukin-28B Gene rs12979860 C/T Polymorphism in Turkish Chronic Hepatitis C Patients and Healthy Individuals
Serpil Taheri et al.
BALKAN MEDICAL JOURNAL (2015)
Hepatitis C: Treatment of difficult to treat patients
Eric G. Hilgenfeldt et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
IL28B polymorphisms predict the virological response to standard therapy in patients with chronic hepatitis C virus genotype 4 infection
Ayman A. Abdo et al.
HEPATOLOGY INTERNATIONAL (2013)
IL28B Polymorphism, Pretreatment CXCL10, and HCV RNA Levels Predict Treatment Response in Racially Diverse HIV/HCV Coinfected and HCV Monoinfected Patients
Marija Zeremski et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2013)
IL28B polymorphism and cytomegalovirus predict response to treatment in Egyptian HCV type 4 patients
Mostafa K. El Awady et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Association of IL28B SNP With Progression of Egyptian HCV Genotype 4 Patients to End Stage Liver Disease
Mostafa K. El-Awady et al.
HEPATITIS MONTHLY (2012)
APASL consensus statements and management algorithms for hepatitis C virus infection
Masao Omata et al.
HEPATOLOGY INTERNATIONAL (2012)
Polymorphisms in interleukin-10 and interleukin-28B genes in Egyptian patients with chronic hepatitis C virus genotype 4 and their effect on the response to pegylated interferon/ribavirin-therapy
Olfat G. Shaker et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Hepatitis C Virus in Arab World: A State of Concern
Mohamed A. Daw et al.
SCIENTIFIC WORLD JOURNAL (2012)
Role of Interleukin 28B rs12979860 C/T Polymorphism on the Histological Outcome of Chronic Hepatitis C: Relationship with Gender and Viral Genotype
Edmondo Falleti et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
IL28B single nucleotide polymorphisms in the treatment of hepatitis C
Christian M. Lange et al.
JOURNAL OF HEPATOLOGY (2011)
Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients
Norma I. Rallon et al.
AIDS (2010)
An overview about hepatitis C: A devastating virus
Nazish Bostan et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2010)
Hepatic ISG Expression Is Associated With Genetic Variation in Interleukin 28B and the Outcome of IFN Therapy for Chronic Hepatitis C
Masao Honda et al.
GASTROENTEROLOGY (2010)
Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study
Andri Rauch et al.
GASTROENTEROLOGY (2010)
IL28B Genotype Is Associated With Differential Expression of Intrahepatic Interferon-Stimulated Genes in Patients With Chronic Hepatitis C
Thomas J. Urban et al.
HEPATOLOGY (2010)
Human interferon-λ3 is a potent member of the type III interferon family
C. Dellgren et al.
GENES AND IMMUNITY (2009)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Vijayaprakash Suppiah et al.
NATURE GENETICS (2009)
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Yasuhito Tanaka et al.
NATURE GENETICS (2009)
Structure and functions of hepatitis C virus proteins: 15 years after
L. Krekulova et al.
FOLIA MICROBIOLOGICA (2006)
Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase
R De Francesco et al.
ANTIVIRAL RESEARCH (2003)
IL-28, IL-29 and their class II cytokine receptor IL-28R
P Sheppard et al.
NATURE IMMUNOLOGY (2003)
Share Paper
